|
KMID : 1039320160160010047
|
|
Journal of Liver Cancer
2016 Volume.16 No. 1 p.47 ~ p.51
|
|
|
Complete Response of Single Nodular Large Hepatocellular Carcinoma with Pulmonary Metastasis by Sequential Transarterial Chemoembolization and Sorafenib: A Case Report
|
|
김기현:Kim Gi-Hyun
유형민:Yu Hyung-Min/임채준:Lim Chae-June/조성범:Cho Sung-Bum
|
|
|
Abstract
|
|
|
|
Current guidelines recommend sorafenib as the first-line molecular target agent for advanced hepatocellular carcinoma (HCC) with extrahepatic metastasis and unresectable HCC. Sorafenib was reported to show survival benefit for patients with advanced HCC. However, complete response is extremely rare in patients treated with sorafenib. Here, we report a 52-year-old man with advanced HCC and pulmonary metastasis who showed complete response by sequential transarterial chemoembolization and continuous sorafenib. Complete response was sustained for 53-month until now.
|
|
|
KEYWORD
|
|
|
Hepatocellular carcinoma, Chemoembolization, Sorafenib
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
 
|